Status:
COMPLETED
Innovative Approaches to Tuberculosis Control
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
Universidade Federal do Rio de Janeiro
Conditions:
Tuberculosis
Eligibility:
All Genders
Brief Summary
This study is designed as a cluster-randomized trial. The cluster unit is at the community level. Communities will be randomized to 1 of 2 study arms: DOTS+ACF or DOTS. Communities in the DOTS+ACF arm...
Detailed Description
Despite free ARV drugs and free TB treatment, and an expanding DOTS program, TB rates have not diminished in this city overall (29), suggesting that DOTS alone will not be sufficient to turn the tide....
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All residents of the study communities will be eligible to be surveyed at their homes, regardless of gender, age, or ethnicity.
Exclusion
Key Trial Info
Start Date :
May 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2011
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT00472316
Start Date
May 1 2007
End Date
May 1 2011
Last Update
August 18 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Health Department of Rio de Janeiro, Brazil
Rio de Janeiro, Brazil